Skip to main content

Advertisement

Table 1 Characteristics of participants in a cervical cancer screening Community Health Campaign by HPV status

From: Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study

Variable Total N HPV negative % HPV positive % Unadjusted Odds Ratio of HPV positivity (95% CI) Adjusteda Odds Ratio of HPV positivity (95% CI)
Total (N, %) N = 243 N = 196 (81%) N = 47 (19%)   
Age (mean, SD) 36 (11) 37 (11) 34 (11) 0.97 (0.94–1.01) 0.96 (0.93–0.99)
Age: categorical
 25–29 yo 97 75 25 1.41 (0.55–3.62) b
 30–39 yo 67 82 18 0.94 (0.33–2.63) b
 40–49 yo 42 90 10 0.45 (0.12–1.69) b
  ≥ 50 yo 37 81 19 1.0 b
Prior screening history
 None prior 197 81 19 1.0 1.0
 Prior screening 46 80 20 1.02 (0.45–2.29) 0.98 (0.41–2.34)
Prior screening type
 No prior screening 197 81 19 1.0 b
 VIA 29 79 21 1.09 (0.42–2.87) b
 Pap smear 15 86 14 1.05 (0.28–3.89) b
 HPV test 1 100 0 too few observations b
HIV serostatus
 HIV - 178 81 19 1.0 1.0
 HIV + 57 79 21 1.13 (0.54–2.36) 1.29 (0.59–2.83)
Family Planning Method
 No method 137 79 21 1.0 1.0
 Modern method 106 83 17 0.76 (0.40–1.46) 0.53 (0.25–1.12)
Family Planning
 No method 137 79 21 1.0 b
 Implant 45 76 24 omitted for collinearity b
 Injectable 39 90 10 0.43 (0.14–1.29) b
 Other 22 86 14 0.59 (0.16–2.13) b
Pregnant
 Not pregnant 216 81 19 1.0 1.0
 Pregnant 12 75 25 1.38 (0.36–5.32) 0.84 (0.20–3.50)
  1. aAdjusted for age, history of previous screening, HIV serostatus, use of a family planning method, and pregnancy
  2. bnot included in the multivariate model